At a glance
- Originator Roche Palo Alto LLC
- Class
- Mechanism of Action Serotonin 4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Irritable bowel syndrome
Most Recent Events
- 03 Nov 1998 No-Development-Reported for Irritable bowel syndrome in USA (PO)
- 13 Mar 1996 New profile
- 13 Mar 1996 Preclinical development for Irritable bowel syndrome in USA (PO)